In April 13th, the official account of Sansure Biotech Inc(688289) announced that in April 13th, the self testing product developed by New Coronavirus (SARS-CoV-2) rapid antigen detection kit ( Sansure Biotech Inc(688289) ) was granted the EU CE qualification. This means that the self-test kit can be sold in EU countries and countries that recognize EU CE certification.
It is reported that covid-19 antigen detection is an important means of epidemic prevention and control, and can be used as an auxiliary diagnosis of covid-19 Sansure Biotech Inc(688289) covid-19 rapid antigen detection reagent self-test product, without detection equipment, is simple and fast. Individuals can collect nasal swabs for operation and produce results in 15-20 minutes, which is convenient for individuals and families to carry out rapid detection of covid-19 virus.
The relevant person in charge of Sansure Biotech Inc(688289) said that Sansure Biotech Inc(688289) covid-19 rapid antigen detection reagent self-test product has obtained the EU ce1434 self-test certificate, indicating that the performance of the company’s immune detection products has been recognized by official institutions, further enriching Sansure Biotech Inc(688289) full scene covid-19 detection solution, expanding and meeting the detection and prevention needs at all levels in the global market, and continuously contributing to the global epidemic prevention and control.
